No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs16828811 |
chr3:177664921-177664922 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs535435450 |
chr3:177664922-177664923 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs371267226 |
chr3:177664966-177664967 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs543311733 |
chr3:177664968-177664969 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs35491071 |
chr3:177664987-177664988 |
Weak transcription Enhancers Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs76974489 |
chr3:177665063-177665064 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs558028352 |
chr3:177665079-177665080 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs556880479 |
chr3:177665089-177665090 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs578209106 |
chr3:177665095-177665096 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs367550942 |
chr3:177665182-177665183 |
Enhancers Weak transcription Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs727335 |
chr3:177665203-177665204 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs542486822 |
chr3:177665216-177665217 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs559514049 |
chr3:177665246-177665247 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs563951858 |
chr3:177665260-177665261 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs572808853 |
chr3:177665270-177665271 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs141307247 |
chr3:177665290-177665291 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs150186403 |
chr3:177665308-177665309 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs113666405 |
chr3:177665328-177665329 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs148893036 |
chr3:177665347-177665348 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs528125072 |
chr3:177665382-177665383 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs551559881 |
chr3:177665411-177665412 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs186327262 |
chr3:177665431-177665432 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs530562350 |
chr3:177665451-177665452 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs558371184 |
chr3:177665467-177665468 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs530853779 |
chr3:177665496-177665497 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs550489296 |
chr3:177665505-177665506 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs567207896 |
chr3:177665607-177665608 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs535496458 |
chr3:177665636-177665637 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs375526284 |
chr3:177665668-177665669 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs548919775 |
chr3:177665727-177665728 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs566174667 |
chr3:177665745-177665746 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs141661176 |
chr3:177665816-177665817 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs534776253 |
chr3:177665845-177665846 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs558354100 |
chr3:177665868-177665869 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs143599452 |
chr3:177665884-177665885 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs537638696 |
chr3:177665893-177665894 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs557730279 |
chr3:177665932-177665933 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs369611156 |
chr3:177666053-177666054 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs542645300 |
chr3:177666054-177666055 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs559348715 |
chr3:177666080-177666081 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs572909038 |
chr3:177666143-177666144 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs201872779 |
chr3:177666161-177666162 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs544747467 |
chr3:177666203-177666204 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs113086848 |
chr3:177666206-177666207 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs555052525 |
chr3:177666209-177666210 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs371876790 |
chr3:177666212-177666213 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs143609896 |
chr3:177666234-177666235 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs550351927 |
chr3:177666245-177666246 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs147196183 |
chr3:177666248-177666249 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs138706328 |
chr3:177666272-177666273 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|